₹4.18▲0.72%
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -0.72 % |
3 Month Return | + 1.72 % |
1 Year Return | + 94.84 % |
Market Stats | |
Previous Close | ₹4.15 |
Open | ₹4.21 |
Volume | 593.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹9.89Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹9.89 Cr |
P/B Ratio | -0.04 |
EPS | 6.8 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
![]() | NA | ₹9.89 Cr | 13.6% | 5.69 | NA | NA |
![]() | NA | ₹17.18 Cr | -6.84% | 0.50 | -₹3 Cr | ₹45 Cr |
![]() | NA | ₹164.28 Cr | 90.19% | 0.58 | NA | NA |
![]() | NA | ₹1,131.02 Cr | 120.9% | 0.54 | ₹27 Cr | ₹550 Cr |
![]() | NA | ₹14.76 Cr | 80.9% | 0.69 | NA | NA |
Organisation | Kobo Biotech Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Kobo Biotech Ltd
Kobo Biotech Ltd has declared their Q3 FY24 results, with a 0% decrease in topline and a 3.38% YoY increase in loss. The EPS for Q3 FY24 is ₹-0.52, which decreased by 4% YoY. Kobo Biotech delivered -5.62% return in the last week, 60.31% return in the last 6 months, and 68.06% YTD return.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, Kobo Biotech has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 166.5%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 44.95% of holdings in Mar 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 54.39% of holdings in Mar 2024 quarter
Price Dip
In the last 3 years, Kobo Biotech stock has moved down by -38.8%
2023 | Y/Y Change | |
---|---|---|
Total Assets | ₹75.33Cr | ↓4.87% |
Total Liabilities | ₹203.31Cr | ↑0.84% |
2023 | Y/Y Change | |
---|---|---|
Operating Cash Flow | ₹0.87Cr | ↓99.07% |
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 44.95% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 54.39% | 0.00 | |
Others | 0.66% | 0.00 |
Kobo Biotech Ltd’s net profit jumped 29.61% since last year same period to ₹-1.26Cr in the Q4 2023-2024. On a quarterly growth basis, Kobo Biotech Ltd has generated -2.44% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2012, Kobo Biotech Ltd has declared dividend of ₹1 - translating a dividend yield of 24.10%.
Read More about DividendsBearish
Neutral
Bullish
Kobo Biotech Ltd is currently in a Bullish trading position according to technical analysis indicators.
Kobo Biotech Ltd (531541) share price today is ₹4.18
Kobo Biotech Ltd is not listed on NSE
Kobo Biotech Ltd is listed on BSE
Today’s traded volume of Kobo Biotech Ltd(531541) is 593.00.
Today’s market capitalisation of Kobo Biotech Ltd(531541) is ₹9.89Cr.
Kobo Biotech Ltd(531541 | Price |
---|---|
52 Week High | ₹6.01 |
52 Week Low | ₹2.05 |
Kobo Biotech Ltd(531541) share price is ₹4.18. It is down -30.45% from its 52 Week High price of ₹6.01
Kobo Biotech Ltd(531541) share price is ₹4.18. It is up 103.90% from its 52 Week Low price of ₹2.05
Kobo Biotech Ltd(531541 | Returns |
---|---|
1 Day Returns | 0.03% |
1 Month Returns | -0.72% |
3 Month Returns | 1.72% |
1 Year Returns | 94.84% |